Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

1.

Bladder cancer.

Lancet.
Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmström PU, Choi W, Guo CC, Lotan Y, Kassouf W.
| Jun 23, 2016
2.

Transgender community voices: a participatory population perspective.

Lancet.
Reisner S, Keatley J, Baral S.
| Jun 16, 2016
3.

Synergies in health and human rights: a call to action to improve transgender health.

Lancet.
Winter S, Settle E, Wylie K, Reisner S, Cabral M, Knudson G, Baral S.
| Jun 16, 2016
4.

Global health burden and needs of transgender populations: a review.

Lancet.
Reisner SL, Poteat T, Keatley J, Cabral M, Mothopeng T, Dunham E, Holland CE, Max R, Baral SD.
| Jun 16, 2016
5.

Six ways for governments to get value from health IT.

Lancet.
Cresswell K, Bates DW, Sheikh A.
| May 21, 2016
6.

Hidden in plain sight: HIV, antiretrovirals, and stillbirths.

Lancet.
Shapiro R, Dryden-Peterson S, Powis K, Zash R, Lockman S.
| May 14, 2016
7.

High-flow oxygen therapy and other inhaled therapies in intensive care units.

Lancet.
Levy SD, Alladina JW, Hibbert KA, Harris RS, Bajwa EK, Hess DR.
| Apr 30, 2016
8.

Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial.

Lancet.
Vestbo J, Anderson JA, Brook RD, Calverley PM, Celli BR, Crim C, Martinez F, Yates J, Newby DE.
| Apr 30, 2016
9.

The map is not the territory: medical records and 21st century practice.

Lancet.
Martin SA, Sinsky CA.
| Apr 25, 2016
11.

The GAS trial - Authors' reply.

Lancet.
Davidson AJ, Disma N, de Graaff JC, Withington DE, McCann ME.
| Apr 16, 2016
12.

Diagnosis and treatment of tricuspid valve disease: current and future perspectives.

Lancet.
Rodés-Cabau J, Taramasso M, O'Gara PT.
| Apr 1, 2016
13.

Barriers in palliative care in China.

Lancet.
Hu K, Feng D.
| Mar 26, 2016
14.

Changing oral vaccine to inactivated polio vaccine might increase mortality.

Lancet.
Fish EN, Flanagan KL, Furman D, Klein SL, Kollmann TR, Jeppesen DL, Levy O, Marchant A, Namachivayam S, Netea MG, Plebanski M, Rowland-Jones SL, Selin LK, Shann F, Whittle HC.
| Mar 12, 2016
16.

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.

Lancet.
Haas NB, Manola J, Uzzo RG, Flaherty KT, Wood CG, Kane C, Jewett M, Dutcher JP, Atkins MB, Pins M, Wilding G, Cella D, Wagner L, Matin S, Kuzel TM, Sexton WJ, Wong YN, Choueiri TK, Pili R, Puzanov I, Kohli M, Stadler W, Carducci M, Coomes R, DiPaola RS.
| May 14, 2016
17.

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.

Lancet.
Rosenberg JE, Hoffman-Censits J, Powles T, van der Heijden MS, Balar AV, Necchi A, Dawson N, O'Donnell PH, Balmanoukian A, Loriot Y, Srinivas S, Retz MM, Grivas P, Joseph RW, Galsky MD, Fleming MT, Petrylak DP, Perez-Gracia JL, Burris HA, Castellano D, Canil C, Bellmunt J, Bajorin D, Nickles D, Bourgon R, Frampton GM, Cui N, Mariathasan S, Abidoye O, Fine GD, Dreicer R.
| May 7, 2016
18.

NextGen HIV prevention: new possibilities and questions.

Lancet.
Mayer KH.
| Mar 12, 2016
19.

Pragmatic trials in critically ill children are CATCHing on.

Lancet.
Randolph AG.
| Apr 23, 2016
20.

Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial.

Lancet.
Schöffski P, Chawla S, Maki RG, Italiano A, Gelderblom H, Choy E, Grignani G, Camargo V, Bauer S, Rha SY, Blay JY, Hohenberger P, D'Adamo D, Guo M, Chmielowski B, Le Cesne A, Demetri GD, Patel SR.
| Apr 16, 2016